Suppr超能文献

CKD 和 ESRD 中的动脉僵硬度和脉压。

Arterial stiffness and pulse pressure in CKD and ESRD.

机构信息

Department of Pharmacology and INSERM (Institut National de la Santéet de la Recherche Médicale) U970-PARCC, Hôpital Européen Georges-Pompidou, Paris, France.

出版信息

Kidney Int. 2012 Aug;82(4):388-400. doi: 10.1038/ki.2012.131.

Abstract

We recognize that increased systolic pressure is the most challenging form of hypertension today and that pulse pressure as an independent cardiovascular risk factor has focused attention on arterial stiffness and wave reflections as the most important factors determining these pressures. In recent years, many studies emphasized the role of arterial rigidity in the development of cardiovascular diseases, and it was shown that stiffening of arteries is associated with increased cardiovascular mortality and morbidity. Moreover,arterial stiffening is linked to decreased glomerular filtration rate, and is predictive of kidney disease progression and the patient’s cardiovascular outcome. Premature vascular aging and arterial stiffening are observed with progression of chronic kidney disease (CKD) and in end-stage renal disease(ESRD). This accelerated aging is associated with outward remodeling of large vessels, characterized by increased arterial radius not totally compensated for by artery wall hypertrophy. Arterial stiffening in CKD and ESRD patients is of multifactorial origin with extensive arterial calcifications representing a major covariate. With aging, the rigidity is more pronounced in the aorta than in peripheral conduit arteries, leading to the disappearance or inversion of the arterial stiffness gradient and less protection of the microcirculation from high-pressure transmission. Various non-pharmacological or pharmacological interventions can modestly slow the progression of arterial stiffness,but arterial stiffness is, in part, pressure dependent and treatments able to stop the process mainly include antihypertensive drugs.

摘要

我们认识到,收缩压升高是当今最具挑战性的高血压形式,而脉压作为一个独立的心血管风险因素,使人们关注动脉僵硬度和波反射,认为它们是决定这些压力的最重要因素。近年来,许多研究强调了动脉僵硬在心血管疾病发展中的作用,研究表明,动脉僵硬与心血管死亡率和发病率增加有关。此外,动脉僵硬与肾小球滤过率降低有关,可预测肾脏疾病的进展和患者的心血管结局。随着慢性肾脏病(CKD)的进展和终末期肾病(ESRD)的发生,会出现过早的血管老化和动脉僵硬。这种加速老化与大血管的外向重塑有关,其特征是动脉半径增加,但动脉壁肥厚不能完全代偿。CKD 和 ESRD 患者的动脉僵硬具有多因素起源,广泛的动脉钙化是一个主要的混杂因素。随着年龄的增长,主动脉的刚性比外周输送动脉更为明显,导致动脉僵硬梯度的消失或反转,对微循环从高压传输的保护作用降低。各种非药物或药物干预可以适度减缓动脉僵硬的进展,但动脉僵硬在一定程度上取决于压力,能够阻止这一过程的主要治疗方法包括降压药物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验